Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
JCI Insight
|
October 23, 2023
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
Ester Sánchez-Tilló, Leire Pedrosa, Ingrid Vila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
Eric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Cancer
|
June 22, 2010
Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas
Joan Maurel, Ana Sofia Martins, Andrés Poveda, et al.
Applied Health Economics and Health Policy
|
May 23, 2019
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
Sherley Diaz-Mercedes, Ivan Archilla, Jordi Camps, et al.
Plos One
|
January 21, 2015
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer
Jaime Feliu, Antonieta Salud, Maria J Safont, et al.
Frontiers in Immunology
|
September 19, 2022
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes
Leire Pedrosa, Carles Foguet, Helena Oliveres, et al.
Cancers
|
December 23, 2022
Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage-A Multicentre Study
Sherley Diaz-Mercedes, Ivan Archilla, Sara Lahoz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2014
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
Virginia Alonso-Espinaco, Miriam Cuatrecasas, Vicente Alonso, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 13, 2006
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Joan Maurel, Marta Martin-Richard, Carlos Conill, et al.
Medicina Clinica
|
March 18, 2011
[Soft tissue sarcomas: clinical practice guidelines]
Xavier García Del Muro, Javier Martín, Joan Maurel, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
JCI Insight
|
October 23, 2023
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
Ester Sánchez-Tilló, Leire Pedrosa, Ingrid Vila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
Eric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Cancer
|
June 22, 2010
Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas
Joan Maurel, Ana Sofia Martins, Andrés Poveda, et al.
Applied Health Economics and Health Policy
|
May 23, 2019
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
Sherley Diaz-Mercedes, Ivan Archilla, Jordi Camps, et al.
Plos One
|
January 21, 2015
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer
Jaime Feliu, Antonieta Salud, Maria J Safont, et al.
Frontiers in Immunology
|
September 19, 2022
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes
Leire Pedrosa, Carles Foguet, Helena Oliveres, et al.
Cancers
|
December 23, 2022
Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage-A Multicentre Study
Sherley Diaz-Mercedes, Ivan Archilla, Sara Lahoz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2014
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
Virginia Alonso-Espinaco, Miriam Cuatrecasas, Vicente Alonso, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 13, 2006
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Joan Maurel, Marta Martin-Richard, Carlos Conill, et al.
Medicina Clinica
|
March 18, 2011
[Soft tissue sarcomas: clinical practice guidelines]
Xavier García Del Muro, Javier Martín, Joan Maurel, et al.
Page
of 12